Explore drug information in your own words.
Type a question in the search bar above to get started. Each question is answered independently.
Select a question to fill the search bar, then submit it or edit it first.
AI can make mistakes. Verify answers against the original sources before relying on them.
| Stem definition | Drug id | CAS RN |
|---|---|---|
| estrogens | 3943 | 28913-23-7 |
None
| Property | Value | Reference |
|---|---|---|
| S (Water solubility) | 0.01 mg/mL | Bocci G, Oprea TI, Benet LZ |
| BA (Bioavailability) | 40 % |
| Property | Description | Value | Unit | Confidence | Similarity |
|---|---|---|---|---|---|
| azlogd74 | LogD at pH 7.4 | 4.164 | Moderate | 0.70 | |
| caco2-efflux | Caco-2 efflux ratio (BA/AB) | 0.908 | Moderate | 0.70 | |
| caco2-intrinsic-papp | Caco-2 intrinsic apparent permeability | 37.411 | 10^-6 cm/s | Moderate | 0.70 |
| dh-clint | Dog hepatocyte intrinsic clearance | 18.578 | uL/min/10^6 cells | Moderate | 0.70 |
| dppb | Dog plasma protein binding (% unbound) | 0.530 | % | Moderate | 0.70 |
| fcs-ppb | Fetal calf serum protein binding (% unbound) | 0.880 | % | Moderate | 0.70 |
| herg | hERG pIC50 | 5.142 | pIC50 | Moderate | 0.70 |
| hh-clint | Human hepatocyte intrinsic clearance | 14.388 | uL/min/10^6 cells | Moderate | 0.70 |
| hlm-clint | Human liver microsomal intrinsic clearance | 34.674 | uL/min/mg protein | Moderate | 0.70 |
| hppb | Human plasma protein binding (% unbound) | 0.570 | % | Moderate | 0.70 |
| kinase-safety-class | ACVR2B,BRAF,CAMK2D,CDK5,EIF2AK3,ERBB2,GRK2,ITK,MAPK10,PDK1,PDK2,PDK4,PRKDC | 13 | |||
| kinase-selectivity-class | GRK2,MAP2K6,PDK1,PDK2 | 4 | |||
| mdck-mdr1-efflux | MDCK-MDR1 efflux ratio | 0.400 | Moderate | 0.70 | |
| mh-clint | Mouse hepatocyte intrinsic clearance | 56.364 | Moderate | 0.70 | |
| mppb | Mouse plasma protein binding (% unbound) | 1.050 | Moderate | 0.70 | |
| nih-mdck-mdr1-efflux | NIH MDCK-MDR1 efflux ratio | 1.774 | Moderate | 0.70 | |
| pfas-class | PFAS structural alert (1 = True, 0 = False) | 0 | |||
| pld-class | Phospholipidosis risk class (1 = positive, 0 = negative) | 0 | Moderate | 0.70 | |
| pppb | Pig plasma protein binding (% unbound) | 0.640 | % | Moderate | 0.70 |
| rh-clint | Rat hepatocyte intrinsic clearance | 92.897 | uL/min/10^6 cells | Moderate | 0.70 |
| rh-fuinc | Rat hepatocyte fraction unbound in incubation | 7.410 | % | Moderate | 0.70 |
| rppb | Rat plasma protein binding (% unbound) | 0.790 | % | Moderate | 0.70 |
| solubility-dd | Solubility at pH 7.4 in DMSO | 3.698 | uM | Moderate | 0.70 |
None
None
None
None
None
| Source | Code | Description |
|---|---|---|
| FDA MoA | N0000000100 | Estrogen Receptor Agonists |
| MeSH PA | D000080066 | Contraceptive Agents, Hormonal |
| MeSH PA | D003271 | Contraceptive Agents, Female |
| MeSH PA | D003278 | Contraceptives, Oral, Hormonal |
| MeSH PA | D004967 | Estrogens |
| MeSH PA | D006728 | Hormones |
| MeSH PA | D012102 | Reproductive Control Agents |
| FDA EPC | N0000175825 | Estrogen |
| CHEBI has role | CHEBI:76988 | xenoestrogens |
| CHEBI has role | CHEBI:35610 | antineoplastic agents |
| CHEBI has role | CHEBI:50114 | estrogens |
None
None
None
None
None
None
None
| ID | Source |
|---|---|
| 4018022 | VANDF |
| CHEBI:135643 | CHEBI |
| 3WF | PDB_CHEM_ID |
| C025723 | MESH_SUPPLEMENTAL_RECORD_UI |
| DB00977 | DRUGBANK_ID |
| 4124 | RXNORM |
| 4698 | MMSL |
| 72166 | MMSL |
| d00229 | MMSL |
| 001286 | NDDF |
| 126097006 | SNOMEDCT_US |
| 15432003 | SNOMEDCT_US |
| C0059716 | UMLSCUI |
| C0015011 | UMLSCUI |
| 68575 | PUBCHEM_CID |
| 5991 | PUBCHEM_CID |
| 437 | INN_ID |
| D004997 | MESH_DESCRIPTOR_UI |
| XF48685MYR | UNII |
| CHEBI:4903 | CHEBI |
None